1. Home
  2. |Insights
  3. |U.K. Government Faces Urgent Pressure to Reform Insolvency Law

U.K. Government Faces Urgent Pressure to Reform Insolvency Law

Client Alert | 2 min read | 03.26.20

In these unprecedented times, the U.K. government is seeking to preserve U.K. businesses and has already introduced significant measures to achieve that aim, including:

  • Deferring VAT payments.
  • Introducing a moratorium to prevent evictions from commercial properties as a result failure to pay rent.
  • Agreeing to pay wages of up to £2,500 per month under the Coronavirus Jobs Retention Scheme.

On March 25, 2020, HM Treasury also wrote to the U.K. banking sector, encouraging them to continue to support U.K. business and to work together with HM Treasury and the regulators “to mitigate the longer lasting effects of COVID-19 on jobs, growth and the U.K. economy”. That involves U.K. lenders offering help and flexibility to their borrowers and maintaining a willingness to extend lending despite the uncertain economic outlook. In summary, HM Treasury states “We must ensure that firms whose business models were viable before this crisis remain viable once it is over.”

Against this background, the government is facing pressure to go further and to pass emergency legislation to change U.K. insolvency laws to afford greater protection to companies and directors against insolvency proceedings. The new measures may include:

  • Removing a creditors’ ability to present a winding up petition and to introduce a 90-day moratorium against creditor action, to be initiated by directors stating that the company is facing temporary liquidity or operational challenges as a result of the coronavirus outbreak.
  • Extending the 10-day moratorium which arises upon the filing by directors of a Notice of Intention to Appoint Administrators.
  • Amending wrongful trading legislation to protect directors who had acted reasonably in managing the company’s affairs but had underestimated the negative impact the COVID-19 outbreak would have on the performance of their business.

The aim of introducing or extending the moratorium periods is to allow businesses a reasonable time, free of the threat of creditor action, to put in place measures to assist them in overcoming the temporary liquidity problem and to continue to trade. Such measures could include smaller businesses availing themselves of the government-backed facilities available under the Coronavirus Business Interruption Loan Scheme (see Crowell & Moring’s Update on the Coronavirus Business Interruption Loan Scheme). The measures would also allow larger businesses to participate in the COVID Corporate Financing Facility, restructure their facilities and businesses or to put in place standstill agreements with their lenders.

The suggested amendments to the wrongful trading legislation would protect directors from inadvertent wrongful trading in a situation where their business’s performance has been impacted almost overnight as a result of the lockdown imposed by the U.K. Government. Clearly, such amendments would have to be carefully worded, but given the lightning speed at which U.K. business has been affected by the lockdown measures, it would seem perverse to hold a director of a business liable for wrongful trading during a period when, regardless of how well they had previously managed their business, it has cratered as a result of factors entirely beyond their control.

We are Here to Help

If you would like to discuss or obtain guidance on any of the points raised in this Alert, please contact any of our lawyers whose details appear below.

Insights

Client Alert | 6 min read | 03.26.24

California Office of Health Care Affordability Notice Requirement for Material Change Transactions Closing on or After April 1, 2024

Starting next week, on April 1st, health care entities in California closing “material change transactions” will be required to notify California’s new Office of Health Care Affordability (“OHCA”) and potentially undergo an extensive review process prior to closing. The new review process will impact a broad range of providers, payers, delivery systems, and pharmacy benefit managers with either a current California footprint or a plan to expand into the California market. While health care service plans in California are already subject to an extensive transaction approval process by the Department of Managed Health Care, other health care entities in California have not been required to file notices of transactions historically, and so the notice requirement will have a significant impact on how health care entities need to structure and close deals in California, and the timing on which closing is permitted to occur....